Verdence Capital Advisors’s AbbVie ABBV Stock Holding History

Verdence Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.07M	Buy	27,317 +1,099	+4%	+$204K	0.35%	68
2025 Q1	$5.49M	Buy	26,218 +765	+3%	+$160K	0.42%	57
2024 Q4	$4.52M	Buy	25,453 +3,127	+14%	+$556K	0.36%	63
2024 Q3	$4.41M	Buy	22,326 +1,164	+6%	+$230K	0.35%	66
2024 Q2	$3.63M	Buy	21,162 +718	+4%	+$123K	0.32%	72
2024 Q1	$3.72M	Sell	20,444 -2,630	-11%	-$479K	0.34%	71
2023 Q4	$3.58M	Buy	23,074 +1,051	+5%	+$163K	0.35%	71
2023 Q3	$3.28M	Buy	22,023 +3,621	+20%	+$540K	0.36%	69
2023 Q2	$2.48M	Sell	18,402 -1,261	-6%	-$170K	0.29%	96
2023 Q1	$3.13M	Sell	19,663 -5,963	-23%	-$950K	0.38%	67
2022 Q4	$4.14M	Sell	25,626 -373	-1%	-$60.3K	0.51%	42
2022 Q3	$3.49M	Buy	25,999 +834	+3%	+$112K	0.48%	51
2022 Q2	$3.85M	Sell	25,165 -14,628	-37%	-$2.24M	0.5%	46
2022 Q1	$6.45M	Buy	39,793 +1,095	+3%	+$178K	0.73%	30
2021 Q4	$5.24M	Buy	38,698 +419	+1%	+$56.7K	0.62%	41
2021 Q3	$4.13M	Buy	38,279 +192	+0.5%	+$20.7K	0.54%	44
2021 Q2	$4.29M	Buy	38,087 +731	+2%	+$82.3K	0.6%	37
2021 Q1	$4.04M	Sell	37,356 -376	-1%	-$40.7K	0.68%	31
2020 Q4	$4.04M	Buy	37,732 +116	+0.3%	+$12.4K	0.77%	28
2020 Q3	$3.3M	Sell	37,616 -2,619	-7%	-$229K	0.76%	30
2020 Q2	$3.95M	Sell	40,235 -3,144	-7%	-$309K	0.97%	24
2020 Q1	$3.31M	Buy	43,379 +4,671	+12%	+$356K	0.99%	22
2019 Q4	$3.43M	Sell	38,708 -525	-1%	-$46.5K	0.84%	29
2019 Q3	$2.97M	Buy	39,233 +4,348	+12%	+$329K	0.83%	30
2019 Q2	$2.54M	Sell	34,885 -2,227	-6%	-$162K	0.73%	36
2019 Q1	$2.99M	Buy	37,112 +4,984	+16%	+$402K	0.81%	39
2018 Q4	$2.96M	Buy	32,128 +8,640	+37%	+$797K	0.83%	33
2018 Q3	$2.22M	Buy	23,488 +1,021	+5%	+$96.6K	0.55%	48
2018 Q2	$2.08M	Sell	22,467 -11	-0%	-$1.02K	0.51%	54
2018 Q1	$2.13M	Sell	22,478 -8,525	-27%	-$807K	0.51%	51
2017 Q4	$3M	Buy	+31,003	New	+$3M	0.71%	40